Antiemetics
The antiemetics are used to treat nausea and vomiting (N&V). If antiemetic drug treatment is indicated, drug choice is guided by the aetiology of nausea and vomiting.
The mechanism of action of some of the commonly used antiemetics is summarised in the table below:
Antiemetics may be grouped into classes. These are shown below with type examples and common indications:
The mechanism of action of some of the commonly used antiemetics is summarised in the table below:
| Antiemetic | Mode of Action |
|---|---|
| Cyclizine | Histamine H1-receptor antagonist |
| Promethazine | Histamine H1-receptor antagonist |
| Ondansetron | Serotonin 5-HT3 receptor antagonist |
| Prochlorperazine | Dopamine D2 receptor antagonist |
| Metoclopramide | Dopamine D2 receptor antagonist 5-HT3 receptor antagonist 5-HT4 receptor agonist |
Antiemetics may be grouped into classes. These are shown below with type examples and common indications:
| Class | Examples | Conditions | Notes |
|---|---|---|---|
| Antihistamines | Cinnarizine Cyclizine Promethazine | Several conditions e.g. motion sickness, Post-op N&V caused by opioids or GA | Adverse effects, e.g. drowsiness and antimuscarinic effects, differ between antihistamines |
| Phenothiazines | Chlorpromazine Prochlorperazine Trifluoperazine | Chemotherapy-induced N&V Radiation-induced N&V Post-op N&V caused by opioids or GA | Act centrally by blocking the chemoreceptor trigger zone. Severe dystonic reactions sometimes occur (especially in children). Prochlorperazine available as a buccal tablet. |
| Other antipsychotic | Haloperidol Levomepromazine | N&V in palliative care | |
| Antiemetic & prokinetic | Metoclopramide | Superior to phenothiazines for emesis associated with gastro-intestinal and biliary disease | Associated with acute dystonic reactions Limit prescribing to no longer than 5 days |
| Dopamine antagonist | Domperidone | Parkinson’s disease | Acts at the chemoreceptor trigger zone. Less likely to cause central effects as does not readily cross the blood-brain barrier |
| 5HT3-receptor antagonists | Granisetron Ondansetron Palonosetron | N&V in patients receiving cytotoxics | Common side effects include:
|